COURSE DESCRIPTION: 
Please join us for a conference on Pharmacologic Management of Status Epilepticus: Status Quo or New Data to Seize? with Karen Berger, Pharm.D., FASHP, FCCM, BCPS, BCCCP.  Dr. Berger will Identify the pharmacologic options for the management of status epilepticus (SE), compare potential third-line treatment strategies in refractory status epilepticus (RSE) and patient factors that contribute to therapeutic decision-making and review guideline recommendations and practice changing literature related to SE and RSE pharmacotherapy.

TARGET AUDIENCE:

Internal Medicine Physicians, Cardiologists, Pulmonologists, Oncologists, Pharmacists, Physician Assistants, Residents, Advanced Practice Registered Nurses, and all other interested healthcare providers

LEARNING OBJECTIVES:

• Identify the pharmacologic options for the management of status epilepticus (SE).
• Compare potential third-line treatment strategies in refractory status epilepticus (RSE) and patient factors that contribute to therapeutic decision-making.
• Review guideline recommendations and practice changing literature related to SE and RSE pharmacotherapy.

FACULTY AND DISCLOSURES:

Karen Berger, Pharm.D., FASHP, FCCM, BCPS, BCCCP
Neurocritical Care Clinical Pharmacist
Baptist Health Boca Raton Regional Hospital
Boca Raton, Florida
 

Karen Berger, Pharm.D., FASHP, FCCM, BCPS, BCCCP, faculty for this educational activity, disclosed that she serves as an advisor for Serb Pharmaceuticals and is a speaker for CSL Behring and Octapharma. She has indicated that her presentation will include discussion of off-label or unapproved uses of products. All relevant financial relationships have been reviewed and mitigated in accordance with ACCME Standards for Integrity and Independence in Accredited Continuing Education.

John F. Rubin, M.D., FACP, director for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.

*Ineligible companies – Companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-1296402, by the Florida Boards of Medicine, Podiatry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Laboratory Personnel, Athletic Trainers and Respiratory Techs. Baptist Health South Florida CE Broker Provider #50-182.